Prevalence of Modifiable Risk Factors for de novo Malignancies After Living Donor Liver Transplantation.

Autor:	Choudhary NS; Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, Haryana, India., Podisatti A; Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, Haryana, India., Dhampalwar S; Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, Haryana, India., Singh KA; Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, Haryana, India., Saraf N; Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, Haryana, India., Soin AS; Institute of Liver Transplantation and Regenerative Medicine, Medanta The Medicity, Gurugram, Haryana, India.
Jazyk:	angličtina
Zdroj:	Journal of clinical and experimental hepatology [J Clin Exp Hepatol] 2024 May-Jun; Vol. 14 (3), pp. 101362. Date of Electronic Publication: 2024 Feb 17.
DOI:	10.1016/j.jceh.2024.101362
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect